Always consult with a qualified healthcare professional before beginning any new supplementation or therapeutic protocol
Pharmacokinetic studies in animals suggest that BPC 157 is rapidly absorbed via intramuscular routes, and it is distributed to a range of tissues including liver, kidney, muscle, and intestine
The exact dosage is dependent on medical condition, response to the treatment, age, and weight
What evidence supports remaining at 2.5 mg of tirzepatide before dose escalation
Vascular recruitment the organised attraction of new blood vessel ingrowth into healing tissue is considered a central mechanism across BPC-157s cross-tissue cytoprotective effects and is described as a defining feature distinguishing it from other growth factors in the healing biology literature
International Journal of Toxicology (2014) 11